10

Click here to load reader

PROOF OF CLAIM AND RELEASE FORM - Amgen Securities Form.pdf · p7451 v.04 08.15.2016 1 01-ca8587 united states district court central district of california western division in re

  • Upload
    hatuong

  • View
    212

  • Download
    0

Embed Size (px)

Citation preview

Page 1: PROOF OF CLAIM AND RELEASE FORM - Amgen Securities Form.pdf · p7451 v.04 08.15.2016 1 01-ca8587 united states district court central district of california western division in re

P7451 v.04 08.15.2016 101-CA8587

UNITED STATES DISTRICT COURTCENTRAL DISTRICT OF CALIFORNIA

WESTERN DIVISION

IN RE AMGEN INC. SECURITIES LITIGATION

Case No. CV 07-2536 PSG (PLAx)Honorable Philip S. Gutierrez

PROOF OF CLAIM AND RELEASE FORM

I. GENERAL INSTRUCTIONS

1. Capitalized terms not defined in this Proof of Claim and Release form (“Claim Form”) have the samemeaningsassetforthintheNoticeofProposedClassActionSettlementandMotionforAttorneys’FeesandExpenses(“SettlementNotice”)thataccompaniesthisClaimFormandtheStipulationandAgreementofSettlement,datedasofJuly20,2016(the“Stipulation”).

2. To be eligible to recover from the Net Settlement Fund in the action entitled In re Amgen Inc. Securities Litigation,CaseNo.CV07-2536PSG (PLAx) (C.D.Cal.) (the “Action”), youmust complete and, on page9,signthisClaimForm.IfyoufailtosubmitaproperlycompletedandaddressedClaimForm,yourclaimmayberejectedandyoumaybeprecludedfromanyrecoveryfromtheNetSettlementFundcreatedinconnectionwiththeSettlementoftheAction.

3. SubmissionofthisClaimForm,however,doesnotassurethatyouwillshareintheNetSettlementFund.

4. YOU MUST MAIL OR SUBMIT YOUR COMPLETED AND SIGNED CLAIM FORM SO THAT IT IS POSTMARKED OR RECEIVED ON OR BEFORE DECEMBER 23, 2016, ADDRESSED AS FOLLOWS:

AMGEN INC. SECURITIES LITIGATIONc/o Epiq

P.O. Box 4178Portland, OR 97208-4178

Tobeconsideredtimely,yourClaimFormmustbepostmarkedorreceivedbythedeadlineabove.Inallothercases,aClaimFormshallbedeemedtohavebeensubmittedwhenactuallyreceivedbytheClaimsAdministrator.

5. IfyouareNOTaClassMember(asdefinedintheSettlementNotice),DONOTsubmitaClaimForm.

6. IfyouareaClassMemberandhavenottimelyandvalidlyrequestedexclusion,youwillbeboundbythetermsoftheSettlementandanyjudgmententeredinthisAction,WHETHERORNOTYOUSUBMITACLAIMFORM.

7. NOTICE REGARDING ELECTRONIC FILES: Certain claimants with large numbers of transactionsmay request, or may be requested, to submit information regarding their transactions in electronic files. Toobtain the mandatory electronic filing requirements and file layout, you may visit the settlement website at www.AmgenSecuritiesLitigation.comor youmay email theClaimsAdministrator’s electronic filing departmentat [email protected]. Any file not in accordance with the required electronic filing formatwill be subject to rejection. No electronic files will be considered to have been properly submitted unless theClaimsAdministratorissuesanemailafterprocessingyourfilewithyourclaimnumbersandrespectiveaccountinformation.Donotassumethatyourfilehasbeenreceivedorprocesseduntilyoureceive thisemail. Ifyoudonotreceivesuchanemailwithin10daysofyoursubmission,youshouldcontacttheelectronicfilingdepartmentat info@AmgenSecuritiesLitigation.comtoinquireaboutyourfileandconfirmitwasreceivedandacceptable.

8. YoushouldbeawarethatitwilltakeasignificantamountoftimetoprocessalloftheClaimFormsandtoadministertheSettlement.Thisworkwillbecompletedaspromptlyastimepermits,giventheneedtoreviewandtabulateeachClaimForm.PleasenotifytheClaimsAdministratorofanychangesofaddress.

Page 2: PROOF OF CLAIM AND RELEASE FORM - Amgen Securities Form.pdf · p7451 v.04 08.15.2016 1 01-ca8587 united states district court central district of california western division in re

P7452 v.04 08.15.2016 202-CA8587

MUSTBE POSTMARKEDORRECEIVEDONORBEFORE

DECEMBER23,2016

In re Amgen Inc. Securities Litigation

PROOF OF CLAIM AND RELEASEUseBlueorBlackInkOnly.

PART I: CLAIMANT IDENTIFICATIONTheClaimsAdministratorwillusethisinformationforallcommunicationsrelevanttothisClaim(includingthecheck,ifeligibleforpayment).Ifthisinformationchanges,youMUSTnotifytheClaimsAdministratorinwritingattheaddressabove.Pleasetypeorprint.BeneficialOwner’sFirstName MI BeneficialOwner’sLastName

Co-BeneficialOwner’sFirstName MI Co-BeneficialOwner’sLastName

EntityName(ifBeneficialOwnerisnotanindividual)

RepresentativeorCustodianName(ifdifferentfromBeneficialOwner(s)listedabove)

Address1(streetnameandnumber)

Address2(apartment,unitorboxnumber)

City State ZIPCode

ForeignCountry(onlyifnotUSA)

LastfourdigitsofSocialSecurityNumberorTaxpayerIdentificationNumber

TelephoneNumber(home) TelephoneNumber(work)– – – –

Email address (Email address is not required, but if you provide it you authorize theClaimsAdministrator to use it in providing youwith information relevant to thisclaim.):

AccountNumber(account(s)throughwhichthesecuritiesweretraded):

Specifyoneofthefollowing:

Individual(s) IRA Estate

Corporation Partnership Trust

UGMACustodian Other

IfyouwereemployedbyAmgen,Inc.atanytimebetweenApril22,2004andMay10,2007,inclusive,pleaseprovidethetitle(s)youheldandthedate(s)duringwhichyouheldanysuchtitle(s).Position StartDate(MMYYYY) EndDate(MMYYYY)

– –

– –

Page 3: PROOF OF CLAIM AND RELEASE FORM - Amgen Securities Form.pdf · p7451 v.04 08.15.2016 1 01-ca8587 united states district court central district of california western division in re

P7453 v.04 08.15.2016 303-CA8587

PART II: TRANSACTIONS IN AMGEN PUBLICLY TRADED COMMON STOCK

1. BEGINNING HOLDINGS – StatethetotalnumberofsharesofAmgenpubliclytradedcommonstockheldasoftheopeningoftradingonApril22,2004.Ifnone,write“0”or“Zero.”(Mustbedocumented.)

•2. PURCHASES DURING THE CLASS PERIOD –Separately list each and everypurchaseofAmgenpublicly tradedcommonstockfromaftertheopeningoftradingonApril22,2004throughandincludingthecloseoftradingonMay10,2007.(Mustbedocumented.)

Purchase Date(List Chronologically)

(MMDDYY)Number of Shares

Purchased Price Per Share

Total Purchase Price (excluding taxes,

commissions, and fees)

● ●

● ●

● ●

● ●

3. PURCHASES DURING 90-DAY LOOKBACK PERIOD – StatethetotalnumberofsharesofAmgenpubliclytradedcommonstockpurchasedfromaftertheopeningoftradingonMay11,2007andincludingthecloseoftradingonAugust8,2007.(Mustbedocumented.Forclaimbalancingpurposesonly.)

•4. SALES DURING THE CLASS PERIOD AND DURING THE 90-DAY LOOKBACK PERIOD– Separatelylisteachandeverysale/dispositionofAmgenpubliclytradedcommonstockfromaftertheopeningoftradingonApril22,2004throughandincludingthecloseoftradingonAugust8,2007.(Mustbedocumented.)

IF NONE, CHECK HERE.

Sale Date(List

Chronologically)(MMDDYY)

Number of Shares Sold

Price Per Share

Total Sale Price (excluding taxes,

commissions, and fees)

● ●

● ●

● ●

● ●

5. ENDING HOLDINGS – StatethetotalnumberofsharesofAmgenpubliclytradedcommonstockheldasofthecloseoftradingonAugust8,2007.Ifnone,write“0”or“Zero.”(Mustbedocumented.)

•IF YOU NEED ADDITIONAL SPACE TO LIST YOUR TRANSACTIONS, YOU MUST

PHOTOCOPY THIS PAGE AND CHECK THIS BOX.

Page 4: PROOF OF CLAIM AND RELEASE FORM - Amgen Securities Form.pdf · p7451 v.04 08.15.2016 1 01-ca8587 united states district court central district of california western division in re

P74

54 v

.04

08.1

5.20

164

04-C

A858

7

PAR

T II

I: T

RA

NSA

CT

ION

S IN

AM

GE

N E

XC

HA

NG

E-T

RA

DE

D C

AL

L O

PTIO

NS

1. B

EGIN

NIN

G H

OL

DIN

GS

– Statethetotalnum

berofA

mgencalloptioncontractsh

eldasoftheopeningoftradingonApril22,2004.If

none,w

rite“0”or“Zero.”(M

ustbedocumented.)

IF N

ON

E, C

HEC

K

HE

RE

.

Stri

ke P

rice

of C

all

Opt

ion

Con

trac

t

Expi

ratio

n D

ate o

f C

all O

ptio

n C

ontr

act

(MM

DDY

Y)

Num

ber

of C

all O

ptio

n C

ontr

acts

in W

hich

You

H

ad a

n O

pen

Inte

rest

● ● ● ●

2. P

UR

CH

ASE

S D

UR

ING

TH

E C

LA

SS P

ER

IOD

– SeparatelylisteachandeverypurchaseofA

mgencalloptioncontractsfrom

aftertheopeningoftradingon

April22,2004throughandincludingthecloseoftradingonM

ay10,2007.(M

ustbedocumented.)

Dat

e of

Pur

chas

e (L

ist

Chr

onol

ogic

ally

) (M

MD

DY

Y)

Stri

ke

Pric

e of

C

all O

ptio

n C

ontr

act

Exp

irat

ion

Dat

e of

Cal

l Opt

ion

Con

trac

t (M

MD

DY

Y)

Num

ber

of C

all

Opt

ion

Con

trac

ts

Purc

hase

d

Purc

hase

Pr

ice

Per

Cal

l O

ptio

n C

ontr

act

Tota

l Pur

chas

e Pri

ce

(exc

ludi

ng ta

xes,

com

miss

ions

, and

fees

)

Inse

rt

an “

E” if

Ex

erci

sed

Inse

rt a

n “X

” if

Expi

red

Exer

cise

Dat

e (M

MD

DYY

)

●●

●●

●●

●●

Page 5: PROOF OF CLAIM AND RELEASE FORM - Amgen Securities Form.pdf · p7451 v.04 08.15.2016 1 01-ca8587 united states district court central district of california western division in re

P74

55 v

.04

08.1

5.20

165

05-C

A858

7

3. S

AL

ES

DU

RIN

G T

HE

CL

ASS

PE

RIO

D A

ND

DU

RIN

G T

HE

90-

DA

Y L

OO

KBA

CK

PE

RIO

D –

Separatelylist

eachandeverysaleofA

mgencalloptioncontractslistedin#2abovefrom

aftertheopeningoftradingonApril22,2004

throughandincludingthecloseoftradingonM

ay10,2007.(M

ustbedocumented.)

IF N

ON

E, C

HEC

K H

ER

E.

Dat

e of

Sal

e (L

ist

Chr

onol

ogic

ally

) (M

MD

DY

Y)

Stri

ke

Pric

e of

C

all O

ptio

n C

ontr

act

Exp

irat

ion

Dat

e of

Cal

l Opt

ion

Con

trac

t (M

MD

DY

Y)

Num

ber

of

Cal

l Opt

ion

Con

trac

ts S

old

Sale

Pri

ce P

er

Cal

l Opt

ion

Con

trac

t

Tota

l Sal

e Pri

ce

(exc

ludi

ng ta

xes,

com

miss

ions

, and

fees

)

●●

●●

●●

●●

4. E

ND

ING

HO

LD

ING

S –SeparatelylistallpositionsinAmgencalloptioncontractsinwhichyouhadanopeninterest

asofthecloseoftradingonMay10,2007.(Mustbedocumented.)

IF N

ON

E, C

HEC

K H

ER

E.

Stri

ke P

rice

of C

all

Opt

ion

Con

trac

t

Expi

ratio

n D

ate o

f C

all O

ptio

n C

ontr

act

(MM

DDY

Y)

Num

ber

of C

all O

ptio

n C

ontr

acts

in W

hich

You

H

ad a

n O

pen

Inte

rest

● ● ● ●IF

YO

U N

EE

D A

DD

ITIO

NA

L S

PAC

E T

O L

IST

YO

UR

TR

AN

SAC

TIO

NS/

HO

LD

ING

S Y

OU

MU

STPH

OT

OC

OPY

TH

IS P

AG

E A

ND

CH

EC

K T

HIS

BO

X.

IF

YO

U D

O N

OT

CH

EC

K T

HIS

BO

X T

HE

SE A

DD

ITIO

NA

L P

AG

ES

WIL

L N

OT

BE

RE

VIE

WE

D.

Page 6: PROOF OF CLAIM AND RELEASE FORM - Amgen Securities Form.pdf · p7451 v.04 08.15.2016 1 01-ca8587 united states district court central district of california western division in re

P74

56 v

.04

08.1

5.20

166

06-C

A858

7

PAR

T I

V –

TR

AN

SAC

TIO

NS

IN A

MG

EN

EX

CH

AN

GE

-TR

AD

ED

PU

T O

PTIO

NS

1. B

EGIN

NIN

G H

OL

DIN

GS

–Statethetotalnum

berofA

mgenputoptioncontractsheldasoftheopeningoftradingonApril22,2004.

(Mustbedocumented.)

IF N

ON

E,

CH

ECK

H

ER

E.

Stri

ke P

rice

of P

ut

Opt

ion

Con

trac

t

Expi

ratio

n D

ate o

f Pu

t Opt

ion

Con

trac

t (M

MD

DYY

)

Num

ber

of P

ut O

ptio

n C

ontr

acts

in W

hich

You

H

ad a

n O

pen

Inte

rest

● ● ● ●

2. S

AL

ES

(WR

ITIN

G O

F PU

T O

PTIO

NS)

DU

RIN

G T

HE

CL

ASS

PE

RIO

D– Separatelylisteachandeverysale(w

riting)ofA

mgenputoptioncontracts

from

aftertheopeningoftradingonApril22,2004throughandincludingthecloseoftradingonM

ay10,2007.(M

ustbedocumented.)

Dat

e of

Sal

e (W

ritin

g) (L

ist

Chr

onol

ogic

ally

)(M

MD

DY

Y)

Stri

ke P

rice

of

Put

Opt

ion

Con

trac

t

Exp

irat

ion

Dat

e of

Put

Opt

ion

Con

trac

t (M

MD

DY

Y)

Num

ber

of P

ut

Opt

ion

Con

trac

ts

Sold

(Wri

tten

)

Sale

Pri

ce P

er

Put O

ptio

n C

ontr

act

Tota

l Sal

e Pri

ce (e

xclu

ding

ta

xes,

com

miss

ions

, and

fe

es)

Inse

rt

an “

E” if

Ex

erci

sed

Inse

rt a

n “X

” if

Expi

red

Exer

cise

Dat

e (M

MD

DYY

)

●●

●●

●●

●●

Page 7: PROOF OF CLAIM AND RELEASE FORM - Amgen Securities Form.pdf · p7451 v.04 08.15.2016 1 01-ca8587 united states district court central district of california western division in re

P74

57 v

.04

08.1

5.20

167

07-C

A858

7

3.

RE

-PU

RC

HA

SES

DU

RIN

G T

HE

CL

ASS

PE

RIO

D A

ND

DU

RIN

G T

HE

90-

DA

Y L

OO

KBA

CK

PE

RIO

D –

Separatelylisteachandeveryre-purchaseofAmgenputoptioncontractslistedin#2abovefrom

aftertheopeningof

tradingonApril22,2004throughandincludingthecloseoftradingonM

ay10,2007.(M

ustbedocumented.)

IF N

ON

E, C

HEC

K H

ER

E.

Dat

e of

Pu

rcha

se (L

ist

Chr

onol

ogic

ally

)(M

MD

DY

Y)

Stri

ke P

rice

of

Put

Opt

ion

Con

trac

t

Exp

irat

ion

Dat

e of

Put

Opt

ion

Con

trac

t (M

MD

DY

Y)

Num

ber

of P

ut

Opt

ion

Con

trac

ts

Purc

hase

d

Purc

hase

Pri

ce

Per

Put O

ptio

n C

ontr

act

Tota

l Pur

chas

e Pri

ce

(exc

ludi

ng ta

xes,

com

miss

ions

, and

fees

)

●●

●●

●●

●●

4. E

ND

ING

HO

LD

ING

S –SeparatelylistallpositionsinAmgenputoptioncontractsinwhichyouhadanopeninterest

asofthecloseoftradingonMay10,2007.(Mustbedocumented.)

IF N

ON

E, C

HEC

K H

ER

E.

Stri

ke P

rice

of P

ut

Opt

ion

Con

trac

t

Expi

ratio

n D

ate o

f Pu

t Opt

ion

Con

trac

t (M

MD

DYY

)

Num

ber

of P

ut O

ptio

n C

ontr

acts

in W

hich

You

H

ad a

n O

pen

Inte

rest

● ● ● ●IF

YO

U N

EE

D A

DD

ITIO

NA

L S

PAC

E T

O L

IST

YO

UR

TR

AN

SAC

TIO

NS/

HO

LD

ING

S Y

OU

MU

STPH

OT

OC

OPY

TH

IS P

AG

E A

ND

CH

EC

K T

HIS

BO

X.

IF Y

OU

DO

NO

T C

HE

CK

TH

IS B

OX

TH

ESE

AD

DIT

ION

AL

PA

GE

S W

ILL

NO

T B

E R

EV

IEW

ED

.

Page 8: PROOF OF CLAIM AND RELEASE FORM - Amgen Securities Form.pdf · p7451 v.04 08.15.2016 1 01-ca8587 united states district court central district of california western division in re

P7458 v.04 08.15.2016 808-CA8587

PART V – TRANSACTIONS IN AMGEN PUBLICLY TRADED BONDS

CodeA=0.125%ConvertibleSeniorNotesDueFebruary1,2011(CUSIP:031162AN0)CodeB=0.375%ConvertibleSeniorNotesDueFebruary1,2013(CUSIP:031162AQ3)

1. BEGINNING AND ENDING HOLDINGS – StatethefacevalueofeachtypeofAmgenBondheldattheopeningoftradingonApril22,2004andatthecloseoftradingonMay10,2007.Ifnone,write“0”or“Zero.”(Mustbedocumented.)

Bond Code (see above)

Face Value of This Bond Held as of the Opening of Trading on April 22, 2004

Face Value of This Bond Held as of the Close of Trading on May 10, 2007

2. PURCHASES – ForeachparticularAmgenBond, state (inchronologicalorder)allpurchases fromafter theopeningoftradingonApril22,2004throughandincludingthecloseoftradingonMay10,2007.Ifnone,write“0”or“Zero.”(Mustbedocumented.)

Bond Code (see above)

Trade Date of Purchase (Month/Day/Year)

Face Value of This Bond Purchased Purchase Price

Aggregate Cost (excluding taxes,

commissions, and fees)

3. SALES – Separatelylist(inchronologicalorder)eachandeverysaleofAmgenBondsfromaftertheopeningoftradingonApril22,2004throughandincludingthecloseoftradingonMay10,2007.(Mustbedocumented.)

IF NONE, CHECK HERE.

Bond Code (see above)

Trade Date of Sale (Month/Day/Year)

Face Value of This Bond Sold Sale Price

Aggregate Received (excluding taxes,

commissions, and fees)

IF YOU NEED ADDITIONAL SPACE TO LIST YOUR TRANSACTIONS, YOU MUSTPHOTOCOPY THIS PAGE AND CHECK THIS BOX.

Page 9: PROOF OF CLAIM AND RELEASE FORM - Amgen Securities Form.pdf · p7451 v.04 08.15.2016 1 01-ca8587 united states district court central district of california western division in re

P7459 v.04 08.15.2016 909-CA8587

II. SUBMISSION TO JURISDICTION OF COURT AND ACKNOWLEDGMENTS1. BysigningandsubmittingthisClaimForm,theclaimant(s)ortheperson(s)actingonbehalfoftheclaimant(s)

certify(ies)that:I(We)submitthisClaimFormunderthetermsofthePlanofAllocationofNetSettlementFunddescribedintheaccompanyingSettlementNotice.I(We)alsosubmittothejurisdictionoftheUnitedStatesDistrictCourtfortheCentralDistrictofCalifornia(the“Court”)withrespecttomy(our)claimasaClassMember(s)andforpurposesofenforcingthereleasessetforthherein.I(We)furtheracknowledgethatI(we)willbeboundbythetermsofanyjudgmententeredinconnectionwiththeSettlementintheAction,includingthereleasessetforththerein.I(We)agreetofurnishadditionalinformationtotheClaimsAdministratortosupportthisclaim,suchasadditionaldocumentationfortransactionsineligibleAmgensecurities,ifrequiredtodoso.I(We)havenotsubmittedanyotherclaimcoveringthesametransactionsinpubliclytradedAmgensecuritiesduringtheallegedClassPeriodandknowofnootherpersonhavingdonesoonmy(our)behalf.III. RELEASES, WARRANTIES, AND CERTIFICATION

1. I(We)herebywarrantandrepresentthatIam(weare)aClassMemberasdefinedintheSettlementNotice,thatIam(weare)notexcludedfromtheClass,thatIam(weare)notoneofthe“ReleasedDefendantParties”asdefinedintheaccompanyingSettlementNotice,andthatI(we)believeIam(weare)eligibletoreceiveadistributionfromtheNetSettlementFundunderthetermsandconditionsofthePlanofAllocation,assetforthintheSettlementNotice.

2. AsaClassMember,I(we)herebyacknowledgefullandcompletesatisfactionof,anddoherebyfully,finally,and forever settle, release, anddischargewithprejudice theReleasedClaims as to each and all of theReleasedDefendantParties(asthesetermsaredefinedintheaccompanyingSettlementNotice).

3. AsaClassMember,I(we)herebyacknowledgethatI(we)willnotbeentitledtoreceivearecoveryinanyotheractionagainstanyoftheReleasedDefendantPartiesbasedonorarisingoutoftheReleasedClaims(asthesetermsaredefinedintheaccompanyingSettlementNotice).

4. ThisreleaseshallbeofnoforceoreffectunlessanduntiltheCourtapprovestheSettlementanditbecomeseffectiveontheEffectiveDate.

5. I(We)herebywarrantandrepresentthatI(we)havenotassignedortransferredorpurportedtoassignortransfer,voluntarilyorinvoluntarily,anymatterreleasedpursuanttothisreleaseoranyotherpartorportionthereof.

6. I(We)herebywarrantandrepresentthatI(we)haveincludedinformationaboutallofmy(our)purchasesandsalesandothertransactionsinpubliclytradedAmgensecuritiesthatoccurredduringtheClassPeriodandthenumberofsecuritiesheldbyme(us),totheextentrequested.

7. I(We)certifythatIam(weare)NOTsubjecttobackuptaxwithholding.(IfyouhavebeennotifiedbytheInternalRevenueServicethatyouaresubjecttobackupwithholding,pleasestrikeoutthepriorsentence.)

I(We)declarethatalloftheforegoinginformationsuppliedbytheundersignedistrueandcorrect.

Executedthis dayof ,2016

SignatureofClaimant Date – –MM DD YY

TypeorprintnameofClaimant

SignatureofJointClaimant,ifany

Date – –MM DD YY

TypeorprintnameofJointClaimant,ifany.

If the Claimant is other than an individual, or is not the person completing this form, the following also must be provided:

Signatureofpersonsigningonbehalfof

ClaimantDate – –

MM DD YY

Typeorprintnameofpersonsigning,onbehalfofClaimant.

CapacityofpersonsigningonbehalfofClaimant,ifotherthananindividual,e.g.,Administrator,Executor,Trustee,President,Custodian,PowerofAttorney,etc.

Page 10: PROOF OF CLAIM AND RELEASE FORM - Amgen Securities Form.pdf · p7451 v.04 08.15.2016 1 01-ca8587 united states district court central district of california western division in re

P74510 v.04 08.15.2016 10010-CA8587

REMINDER CHECKLIST:

1. PleasesignthisClaimForm.

2. Remembertoattachsupportingdocumentation,ifavailable.DONOTHIGHLIGHTTHECLAIMFORMORYOURSUPPORTINGDOCUMENTATION.

3. DoNOTsendoriginalstockcertificatesororiginalbrokeragestatements.

4. KeepacopyofyourClaimFormforyourrecords.

5. TheClaimsAdministratorwillacknowledgereceiptofyourClaimFormbymail,within60days.Yourclaimisnotdeemedsubmitteduntilyoureceiveanacknowledgmentpostcard.Ifyoudonotreceiveanacknowledgmentpostcardwithin60days,pleasecalltheClaimsAdministratortoll-freeat800-462-2317.

6. IfyoumoveaftersubmittingthisClaimForm,pleasenotifytheClaimsAdministratorof thechangeinyouraddress.

THIS CLAIM FORM MUST BE POSTMARKED OR RECEIVED NO LATER THAN DECEMBER 23, 2016.

Amgen Inc. Securities Litigationc/oEpiq

P.O.Box4178Portland,OR97208-4178